When health policy and empirical evidence collide: The case of cigarette package warning labels and economic consumer surplus
Author
Abstract
Suggested Citation
DOI: 10.2105/AJPH.2013.301737
Download full text from publisher
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Helen G. Levy & Edward C. Norton & Jeffrey A. Smith, 2018.
"Tobacco Regulation and Cost-Benefit Analysis: How Should We Value Foregone Consumer Surplus?,"
American Journal of Health Economics, University of Chicago Press, vol. 4(1), pages 1-25, Winter.
- Helen G. Levy & Edward C. Norton & Jeffrey A. Smith, 2018. "Tobacco Regulation and Cost-Benefit Analysis: How Should We Value Foregone Consumer Surplus?," American Journal of Health Economics, MIT Press, vol. 4(1), pages 1-25, Winter.
- Helen Levy & Edward C. Norton & Jeffrey A. Smith, 2016. "Tobacco Regulation and Cost-Benefit Analysis: How Should We Value Foregone Consumer Surplus?," NBER Working Papers 22471, National Bureau of Economic Research, Inc.
- Helen Levy & Edward Norton & Jeffrey Smith, 2016. "Tobacco Regulation and Cost-Benefit Analysis: How Should we Value Foregone Consumer Surplus?," Working Papers id:11159, eSocialSciences.
- Philip DeCicca & Donald Kenkel & Feng Liu & Hua Wang, 2017.
"Behavioral Welfare Economics and FDA Tobacco Regulations,"
Advances in Health Economics and Health Services Research, in: Human Capital and Health Behavior, volume 25, pages 143-179,
Emerald Group Publishing Limited.
- Philip DeCicca & Donald S. Kenkel & Feng Liu & Hua Wang, 2016. "Behavioral Welfare Economics and FDA Tobacco Regulations," NBER Working Papers 22718, National Bureau of Economic Research, Inc.
More about this item
Keywords
article; decision making; emotion; empirical research; food and drug administration; health care policy; human; legal aspect; packaging; psychological aspect; risk factor; smoking; tobacco; tobacco dependence; United States; Choice Behavior; Emotions; Empirical Research; Health Policy; Humans; Product Packaging; Risk Factors; Smoking; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:aph:ajpbhl:10.2105/ajph.2013.301737_3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Christopher F Baum (email available below). General contact details of provider: https://www.apha.org .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.